Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Gamal Abdelhady"'
Publikováno v:
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 14 (2021)
A relatively recent addition to the arsenal of antidiabetic drugs used for the treatment of type 2 diabetes mellitus (T2DM) has been the “incretin mimetics,” a group of drugs that work on the glucagon-like peptide-1 (GLP-1) receptor and enhance i
Externí odkaz:
https://doaj.org/article/4c46ab65d1a542a888d55dcb8f178126
Autor:
Yasser Mostafa Gohary, Ebtehal Gamal Abdelhady, Aya Nagy Sayed, Laila Ahmed Rashed, Hanan Abd El Razik Kamel
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 13, Iss 1, Pp 1-8 (2024)
Abstract Background Vitiligo is classified as an acquired chronic depigmentation disorder that includes the destruction of epidermal melanocytes. It affects 0.5–1% of the population all over the world. Wnt signaling pathway is vital in melanocytes
Externí odkaz:
https://doaj.org/article/613bced67cb64cdd93700eb3cdcc7b89
Autor:
Basma Emad Aboulhoda, Asmaa Mohammed ShamsEldeen, Sarah A. Abd El-Aal, Ebtehal Gamal Abdelhady, Ghada Mahmoud Abdelaziz, Laila A. Rashed, Rania Elsayed Hussein, Mohamed Mansour Khalifa, Heba Morsi
Publikováno v:
Folia Biologica. 69:1-9
The present study was conducted to evaluate the effect of thymoquinone (TQ) on hepatocellular carcinoma (HCC) in rats. Our study has reported that TQ treatment of experimentally-induced HCC results in the up-regulation of the Jun-N-terminal kinase an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27a990e97421bea1296c1a1c2ab4e9d5
https://doi.org/10.3409/fb_69-1.01
https://doi.org/10.3409/fb_69-1.01
Publikováno v:
Cardiology & Vascular Research. 5
Background: Previous trials showed a promising potential use of epinephrine in the treatment of no-reflow phenomenon (the no-reflow phenomenon is multiple pathogenetic processes, which may be attributed to ischemic injuries, distal atherothrombotic e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb7b78a4b9e3f646363b49c5e98d1a6c
https://doi.org/10.33425/2639-8486.1120
https://doi.org/10.33425/2639-8486.1120
Autor:
Mohamed Elbordy, Ali Alamin, Gamal Abdelhady, Sami Nouh, Ahmed H Dawood, Ibrahim Altaj, Abdulaziz Aboshahba, Abdulaziz Rezq, Hani Khalaf, Abdelmohsen Mostafa, Raphael Solomon
Publikováno v:
Cardiology & Vascular Research. 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::124e82ee3ce361af8537b19fccf2adb7
https://doi.org/10.33425/2639-8486.1086
https://doi.org/10.33425/2639-8486.1086
Autor:
Ebtehal Gamal Abdelhady, Nivin Sharawy, Sherif S. Hassan, Dalia Azmy Elberry, Shaimaa Nasr Amin, Mira Farouk Youssef, Nashwa El Tablawy, Laila A. Rashed
Publikováno v:
Frontiers in Physiology
Frontiers in Physiology, Vol 12 (2021)
Frontiers in Physiology, Vol 12 (2021)
Diabetes mellitus (DM) is a multisystem endocrine disorder affecting the brain. Mesenchymal stem cells (MSCs) pretreated with Melatonin have been shown to increase the potency of MSCs. This work aimed to compare Melatonin, stem cells, and stem cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c28c9f8aae93fec449c95bdc922f336
https://pubmed.ncbi.nlm.nih.gov/33815140
https://pubmed.ncbi.nlm.nih.gov/33815140
Publikováno v:
Clinical Medicine Insights. Endocrinology and Diabetes
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 14 (2021)
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 14 (2021)
A relatively recent addition to the arsenal of antidiabetic drugs used for the treatment of type 2 diabetes mellitus (T2DM) has been the “incretin mimetics,” a group of drugs that work on the glucagon-like peptide-1 (GLP-1) receptor and enhance i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea6d82c04783f7b3eb34c9b0054436c6
https://doi.org/10.1177/11795514211051697
https://doi.org/10.1177/11795514211051697
Autor:
Hany Ragy, Abdel-Rahman Hassan, Wail Nammas, Ahmed Emam, Gamal Sheiban, Maged El-Abbady, Tarek Mohammed Rashid, Adel El-Itriby, Salwa Labib, Wael El-Kilany, Gamal Abdelhady, Wael Abu-Shokka, Ayman Mortada, Tarek Zaki, Mohamed Abdel-Kader
Publikováno v:
Ain Shams Medical Journal. 65:141-150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d8ca2cb1e6c2c44f9519aa78e326ab0
https://doi.org/10.12816/0013854
https://doi.org/10.12816/0013854
Autor:
Shaimaa Nasr Amin, Nivin Sharawy, Nashwa El Tablawy, Dalia Azmy Elberry, Mira Farouk Youssef, Ebtehal Gamal Abdelhady, Laila Ahmed Rashed, Sherif Sabry Hassan
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Diabetes mellitus (DM) is a multisystem endocrine disorder affecting the brain. Mesenchymal stem cells (MSCs) pretreated with Melatonin have been shown to increase the potency of MSCs. This work aimed to compare Melatonin, stem cells, and stem cells
Externí odkaz:
https://doaj.org/article/caee02c93ea846f299ae63e42dd97a43